Clinical Trials Browser

Phase 2 × INDUSTRY × temsirolimus × Clear all

NCT01827267 2018-07-03

Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer

Phase 2 Completed

62 enrolled 12 charts

Lung Neoplasms

NCT00062751 2011-04-15

Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms

Phase 2 Completed

108 enrolled 4 charts

Breast Neoplasms, Neoplasms